|
|
||||||||
Methods |
Correspondence to: Teruo Miyazawa, To whom correspondence should be addressed., miyazawa{at}biochem.tohoku.ac.jp (E-mail)
Maillard reactions are among the most important of the chemical and oxidative changes occurring in food and biological samples that contribute to food deterioration and to the pathophysiology of human disease. Although the association of lipid glycation with this process has recently been shown, the number of lipid glycation products in food and biological materials has not been clear. In this study, we synthesized the Amadori products derived from the glycation of phosphatidylethanolamine (PE), i.e., Amadori-PEs. Dioleoyl PE was incubated with glucose and lactose for 15 days, and the resultant Amadori-PEs were purified and isolated using solid phase extraction followed by HPLC. With this procedure, essentially pure (>98% purity) Amadori-PEs glycated with glucose (Glc-PE) and with lactose (Lac-PE) were obtained and used as standards in the subsequent studies.
To determine the presence of Amadori-PEs in food and biological samples, the carbonyl group of Amadori-PEs was ultraviolet (UV)-labeled with 3-methyl-2-benzothiazolinone hydrazone, and the labeled Amadori-PEs were analyzed with normal phase HPLC-UV (318 nm). The detection limit was 4.5 ng (5 pmol) for Glc-PE and 5.3 ng (5 pmol) for Lac-PE. Among the several food samples examined, infant formula and chocolate contained a high amount of both Glc-PE and Lac-PE over wide concentration ranges, such as 1.5112 µg/g. Testing biological materials showed Amadori-PE (Glc-PE) was detectable in rat plasma. Oak, J-H., K. Nakagawa, and T. Miyazawa. UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples. J. Lipid Res. 2002. 43: 523529.
Supplementary key words: glycation, phosphatidylethanolamine, Amadori product determination, 3-methyl-2-benzothiazolinone hydrazone, HPLC-UV
This article has been cited by other articles:
![]() |
T. MIYAZAWA, D. IBUSUKI, S. YAMASHITA, and K. NAKAGAWA Analysis of Amadori-glycated Phosphatidylethanolamine in the Plasma of Healthy Subjects and Diabetic Patients by Liquid Chromatography-Tandem Mass Spectrometry Ann. N.Y. Acad. Sci., April 1, 2008; 1126(1): 291 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Higuchi, K. Nakagawa, T. Tsuzuki, T. Suzuki, S. Oikawa, and T. Miyazawa Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor J. Lipid Res., May 1, 2006; 47(5): 964 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakagawa, J.-H. Oak, O. Higuchi, T. Tsuzuki, S. Oikawa, H. Otani, M. Mune, H. Cai, and T. Miyazawa Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes J. Lipid Res., November 1, 2005; 46(11): 2514 - 2524. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. MIYAZAWA, J.-H. OAK, and K. NAKAGAWA Tandem Mass Spectrometry Analysis of Amadori-Glycated Phosphatidylethanolamine in Human Plasma Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 280 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. NAKAGAWA, J.-H. OAK, and T. MIYAZAWA Angiogenic Potency of Amadori-Glycated Phosphatidylethanolamine Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 413 - 416. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |